Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice (Q38309530)

2 September 2017

Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice (English)

1 reference

2 September 2017

0 references

1 reference

Boundy VA

1

1 reference

PubMed ID

10938239

2 September 2017

Cincotta AH

series ordinal

2

1 reference

2 September 2017

1 August 2000

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

2 September 2017

1 reference

2 September 2017

279

1 reference

2 September 2017

R505-14

1 reference

2 September 2017

2

1 reference

Alpha 2-agonist binding sites in brain: [125I]para-iodoclonidine versus [3H]para-aminoclonidine.

2 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Intra-ventromedial hypothalamic injection of glutamate stimulates brown adipose tissue thermogenesis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

The dorsomedial hypothalamic nucleus revisited: 1998 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Relationships between medial hypothalamic alpha 2-receptor binding, norepinephrine, and circulating glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Hyperinsulinemia increases norepinephrine metabolism in the ventromedial hypothalamus of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Elevated Hypothalamic Norepinephrine Content in Mice with the Hereditary Obese-Hyperglycemic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Age- and diabetes-associated alterations in regional brain norepinephrine concentrations and adrenergic receptor populations in C57BL/KsJ mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Swimming stress that causes hyperglycemia increases in vivo release of noradrenaline, but not acetylcholine, from the hypothalamus of conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Chronic reserpine administration selectively up-regulates beta 1- and alpha 1b-adrenergic receptors in rat brain: an autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Feeding and body-weight regulation by hypothalamic neuropeptides--mediation of the actions of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Higher alpha-noradrenergic receptors in paraventricular nucleus of obese Zucker rats: decline after food deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Maternal hormonal manipulations in rats cause obesity and increase medial hypothalamic norepinephrine release in male offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Obesity-prone and -resistant rats differ in their brain [3H]paraminoclonidine binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Reduced glucose-induced neuronal activation in the hypothalamus of diet-induced obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Insulin selectively downregulates alpha2-adrenoceptors in the arcuate and dorsomedial nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Defective glucoregulation of brain alpha 2-adrenoceptors in obesity-prone rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Altered alpha 1-adrenoceptor binding in intact and adrenalectomized obese Zucker rats (fa/fa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Central catecholamine levels in genetically obese mice (obob and dbdb)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Chronic ventromedial hypothalamic infusion of norepinephrine and serotonin promotes insulin resistance and glucose intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on beta-adrenoceptors in rat brain: autoradiographic and functional studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob/ob).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Increases in α-adrenergic receptors in the hypothalamus of the genetically obese mouse (ob/ob)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Effects of food restriction and mutation on central catecholamine levels in genetically obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Beta-adrenoceptor subtypes in the human brain: autoradiographic localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Central nervous system regulation of liver and adipose tissue metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: origin and modulation by alpha2-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

The modulatory effect of the hypothalamus on glucagon and insulin secretion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Circulating free fatty acids, insulin, and glucose during chemical stimulation of hypothalamus in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Hypothalamically-induced insulin release and its potentiation during oral and intravenous glucose loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Differential localization of alpha 2-adrenergic receptor subtypes in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

Sympathetic nerve activity after discrete hypothalamic injections of L-glutamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.2000.279.2.R505

10.1152/AJPREGU.2000.279.2.R505

21 January 2018

Identifiers

DOI

0 references

PubMed ID

10938239

1 reference

PubMed ID

10938239